DGX vs OKTA · P/E 22, rev $5.94B vs P/E 84, rev $1.57B
Quest Diagnostics Incorporated (DGX) versus Okta Inc (OKTA) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Okta Inc (OKTA) is a software - infrastructure company listed on NASDAQ.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported OKTA revenue for 2026-07-31 was $1.57B. Net income was $190.0M. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
Not investment advice. Open the DGX and OKTA stock pages for the full models.
Not investment advice.